Elevating Awareness for Artax’s Groundbreaking Immunotherapy

In support of Artax’s AX-158 novel immunotherapy going into human trials, Scratch developed and implemented a social strategy aimed to promote awareness of the company and the diseases they are fighting, while promoting executives as thought leaders.

• Fully managed organic social media, including creative development, posting, and analysis
• Strategic small-budget boosting of organic LinkedIn posts to drive reach and engagement outside follower base
• Amplification of Artax POV through thought leadership from executives